patients were randomly allocated to receive continuous therapy with cyclophosphamide , methotrexate , 5-fluorouracil , vincristine , prednisone ( cmfvp -c , 86 patients ) , intermittent cmfvp ( cmfvp -i , 109 patients ) , or intermittent cafvp ( 107 patients ) .
C0010583
cyclophosphamide
C0054438
cafvp